Data / Form D filings / PROFECTUS BIOSCIENCES, INC
PROFECTUS BIOSCIENCES, INC: Form D filings
PROFECTUS BIOSCIENCES, INC, a biotechnology company in Baltimore, MD, filed 9 Form D notices with the SEC between 2009 and 2016. The latest, on December 12, 2016, reports $300,000 sold of a $4 million offering to 5 investors.
Find out what PROFECTUS BIOSCIENCES, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6411 BECKLEY STREET, SUITE N201, Baltimore, MD, 21224
- Phone
- (443) 743-1100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1444253
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 12, 2016 | Amendment | $4,000,000 | $300,000 | $3,700,000 | 5 | May 5, 2016 | sec.gov |
| May 13, 2016 | New notice | $500,000 | $300,000 | $200,000 | 5 | May 5, 2016 | sec.gov |
| Aug 4, 2014 | Amendment | $7,541,206 | $7,541,206 | $0 | 1 | Jul 20, 2009 | sec.gov |
| Apr 17, 2014 | Amendment | $7,541,206 | $7,291,206 | $250,000 | 1 | Jul 20, 2009 | sec.gov |
| Aug 13, 2013 | Amendment | $7,041,206 | $7,041,206 | $0 | 1 | Jul 20, 2009 | sec.gov |
| Feb 11, 2013 | Amendment | $7,041,206 | $7,041,206 | $0 | 1 | Jul 17, 2009 | sec.gov |
| Jul 18, 2011 | Amendment | $6,791,206 | $6,791,206 | $0 | 1 | Jul 17, 2009 | sec.gov |
| Apr 6, 2010 | Amendment | $6,041,205 | $6,041,205 | $0 | 1 | Jul 20, 2009 | sec.gov |
| Jul 28, 2009 | New notice | $5,041,205 | $5,041,205 | $0 | 1 | Jul 20, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William K. Haseltine | Director | |
| Michael K. Greenebaum | Director | |
| Thomas G. Pease | Executive Officer, Director | |
| Thomas A. Lynch | Director | |
| Frederick C. Tecce | Director | |
| Brian K. Adamsky | Director | |
| Terry A. Lierman | Director | |
| Jeffrey N. Meshulam | Executive Officer, Director | |
| M.G. A. Sarngadharan | Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Dec 12, 2016 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PROFECTUS BIOSCIENCES, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.